Supply of Pharmaceutical Products for Oncology and Neurology Programs

This contract involves the supply of pharmaceutical products necessary for the implementation of oncology and neurology drug programs. The contract is divided into 75 distinct packages, each representing a separate item. Key packages include various medications such as Cetuximab, Panitumumab, and Trastuzumab, among others. Detailed descriptions of each package can be found in Annex 1a of the procurement documentation. Suppliers must ensure that the products offered comply with the Polish Pharmaceutical Law and other relevant legal regulations. The quantities required are specified in standard packaging forms such as tubes, bottles, and tablets, with a maximum of 100 units per package. Hospital packaging is excluded from the evaluation. Equivalent forms of medication are allowed, and all products must be from the same manufacturer to ensure compatibility. Additionally, all offered medications must be listed as reimbursable drugs according to the current regulations at the time of bid submission, and the proposed prices must not exceed the funding limits for each active substance.